Youliang X. Weng

No. 420 Fuma Road
Fuzhou, 350014, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Label-free cervical cancer detection in tissue samples using Raman spectroscopy combined with machine learning technology.

Label-free cervical cancer detection in tissue samples using Raman spectroscopy combined with machine learning technology.

Journal: Analytical methods : advancing methods and applications
Published: July 03, 2026

Label-free detection of glioma radioresistance using exosomal SERS spectra and machine learning.

Label-free detection of glioma radioresistance using exosomal SERS spectra and machine learning.

Journal: Biosensors & bioelectronics
Published: May 13, 2026

Dynamic prognostic nutritional index trajectories predict survival outcomes in nasopharyngeal carcinoma with persistently undetectable plasma Epstein-Barr virus DNA.

Dynamic prognostic nutritional index trajectories predict survival outcomes in nasopharyngeal carcinoma with persistently undetectable plasma Epstein-Barr virus DNA.

Journal: Frontiers in nutrition
Published: February 07, 2026

EBV genome-guided transcriptomic re-annotation reveals molecular subtypes of nasopharyngeal carcinoma informing prognosis and treatment.

EBV genome-guided transcriptomic re-annotation reveals molecular subtypes of nasopharyngeal carcinoma informing prognosis and treatment.

Journal: Rhinology
Published: October 13, 2025

Noninvasive nasopharyngeal cancer screening via salivary DNA detection using label-free surface-enhanced Raman spectroscopy.

Noninvasive nasopharyngeal cancer screening via salivary DNA detection using label-free surface-enhanced Raman spectroscopy.

Journal: Talanta
Published: August 29, 2025

Comparative effectiveness of Volumetric Modulated Arc Therapy versus tomotherapy in locally advanced nasopharyngeal carcinoma: a propensity score-matched retrospective cohort study.

Comparative effectiveness of Volumetric Modulated Arc Therapy versus tomotherapy in locally advanced nasopharyngeal carcinoma: a propensity score-matched retrospective cohort study.

Journal: Radiation oncology (London, England)
Published: August 15, 2025

Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival.

Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival.

Journal: JCO precision oncology
Published: January 08, 2025

Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors.

Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors.

Journal: Journal for immunotherapy of cancer
Published: September 26, 2024

Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy.

Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy.

Journal: BMC cancer
Published: September 14, 2024

Identifying chemotherapy beneficiaries in nasal and paranasal sinus cancers: epidemiological trends and machine learning insights.

Identifying chemotherapy beneficiaries in nasal and paranasal sinus cancers: epidemiological trends and machine learning insights.

Journal: European journal of medical research
Published: July 19, 2024

Selection of induction chemotherapy cycles for stage N3 nasopharyngeal carcinoma based on pre-treatment plasma EBV DNA.

Selection of induction chemotherapy cycles for stage N3 nasopharyngeal carcinoma based on pre-treatment plasma EBV DNA.

Journal: Scientific reports
Published: July 17, 2024

Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein-Barr virus DNA.

Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein-Barr virus DNA.

Journal: Therapeutic advances in medical oncology
Published: March 18, 2024
Showing 1-12 of 31

Last Updated: 09/26/2026